We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

This study has been terminated.
(low enrolling participants)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01159327
First Posted: July 9, 2010
Last Update Posted: November 11, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bayer
Information provided by (Responsible Party):
Ji-youn Han, National Cancer Center, Korea
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)